‘What’s next for patient advocacy?’ will take place on Tuesday 6th July at 8.30am
News
Lecanemab wins breakthrough therapy designation in Alzheimer’s disease
Designation is based on data from a Phase IIb study including 856 patients with mild Alzheimer’s disease
Novartis announces digital collaboration with Hewlett Packard Enterprise
Collaboration aims to accelerate Novartis’ use of data and digital technologies
Arcus, Gilead prep Phase III studies of anti-TIGIT domvanalimab
Preparations come on the heels of positive results from the Phase II ARC-7 study
‘New’ GSK spotlights growth potential of vaccines and speciality medicines
British drugmaker predicted a substantial £33bn sales ambition by 2031 in investor update
Novartis reveals long-term results for MS therapy Kesimpta
B-cell targeting therapy preserved patients’ IgG/IgM levels, with no increased risk of serious infections
Cancer Research UK partners with Aleta Biotherapeutics on blood cancer therapy
Partnership will advance the early clinical development of CAR-T cell engager candidate ALETA-001
NHSX sets out new ‘patient-centred’ data strategy
Strategy includes proposals for patients to easily access their test results, medication lists, procedures and care plans
Gov’t injects £64m into clinical research plan
Funding will go toward the first phase of activity of ‘The Future of UK Clinical Research Delivery’ plan
INTCR delivers another set of hard-fought finals days
The 2021 International Clinical Researcher of the Year virtual finals days took place over the 15th and 16th of June.
US approves Pradaxa as oral blood thinning med for children
First oral blood thinning drug approved for paediatric patients in the US
ABPI launches new Patient Advisory Council
The council will be comprised of senior leaders from the patient charity sector
EU green lights AZ, MSD’s rare disease therapy Koselugo
Drug approved to treat children with neurofibromatosis type 1 and plexiform neurofibromas
NHS England announces extra funding for young people’s mental health services
An extra £40m will go toward enhancing mental health services for children and young people
US approval for OTC use of Bayer’s Astepro
Approval makes Astepro the first and only OTC steroid free antihistamine nasal spray available in the US
